NCR1 and hepatocellular carcinoma: Blocking NKp46 in vitro significantly reduced the cytotoxic capability of circulating NK cells against K562 and hepatoma cell lines, suggesting that NKp46 may be a major lytic receptor and directly involved in the regulation of NK cell cytotoxicity.